How to Reconstitute CJC-1295 and GHRP-2 Blend: Laboratory Protocol
How to Reconstitute CJC-1295 and GHRP-2 Blend: Laboratory Protocol How to Reconstitute CJC-1295 and GHRP-2 Blend: Laboratory Protocol How to Reconstitute CJC-1295 and GHRP-2 Blend: Laboratory Protocol The CJC-1295 and GHRP-2 blend represents a sophisticated co
How to Reconstitute CJC-1295 and GHRP-2 Blend: Laboratory Protocol
How to Reconstitute CJC-1295 and GHRP-2 Blend: Laboratory Protocol
How to Reconstitute CJC-1295 and GHRP-2 Blend: Laboratory Protocol
The CJC-1295 and GHRP-2 blend represents a sophisticated combination of growth hormone-releasing compounds designed for advanced in vitro research applications. CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH), functions synergistically with GHRP-2, a hexapeptide growth hormone secretagogue. This dual-component formulation enables researchers to investigate the complex interactions between GHRH and ghrelin receptor pathways in controlled laboratory environments. The lyophilised preparation ensures maximum stability and research-grade purity for precise experimental protocols.
Required Laboratory Materials
CJC-1295 + GHRP-2 blend vial (2mg/2mg lyophilised)
Bacteriostatic water for injection (BWFI) or sterile water for injection
Sterile syringes (1mL and 3mL capacities)
Sterile needles (25-27 gauge, 1-inch length)
Alcohol swabs (70% isopropanol)
Laminar flow hood or sterile work environment
Vial crimpers and sterile rubber stoppers
Laboratory-grade refrigeration unit
Precision analytical balance
Sterile amber glass vials for aliquoting
Pre-Reconstitution Laboratory Preparation
Establish a sterile working environment within a laminar flow hood, ensuring all surfaces are thoroughly decontaminated with appropriate laboratory-grade disinfectants. Allow the lyophilised vial to equilibrate to room temperature for approximately 15-20 minutes before initiating reconstitution procedures. Verify that all reconstitution materials maintain sterile integrity and inspect the lyophilised cake for uniformity and absence of discoloration. Calculate the desired final concentration based on experimental requirements, considering that the total peptide content equals 4mg combined mass.
Prepare the chosen solvent by allowing refrigerated bacteriostatic water to reach room temperature naturally. Avoid rapid temperature changes that may compromise solvent quality or create condensation within the working environment. Organize all materials within easy reach of the sterile field to minimize contamination risks during the reconstitution sequence.
Step-by-Step Reconstitution Protocol
Step 1: Using sterile technique, remove the aluminum cap from the lyophilised vial and thoroughly swab the rubber stopper with 70% isopropanol. Allow the alcohol to evaporate completely before proceeding with needle insertion.
Step 2: Draw the calculated volume of bacteriostatic water into a sterile syringe, ensuring no air bubbles remain in the syringe barrel. Insert the needle through the rubber stopper at a slight angle to prevent coring.
Step 3: Direct the solvent stream toward the vial wall rather than directly onto the lyophilised cake to prevent peptide degradation through mechanical agitation. Inject the solvent slowly and steadily to maintain gentle reconstitution conditions.
Step 4: Withdraw the needle and allow the vial to stand undisturbed for 2-3 minutes, permitting natural dissolution of the peptide matrix. Avoid vigorous shaking or vortexing, which may denature the peptide chains.
Step 5: Gently swirl the vial in circular motions until complete dissolution is achieved. The reconstituted solution should appear clear and colorless without visible particulates or precipitation.
Step 6: If immediate use is not required, transfer appropriate aliquots to sterile amber vials to minimize light exposure and facilitate controlled experimental dosing.
Concentration Options
1.0 mL
2.0 mg/mL
4.0 mg/mL
2.0 mL
1.0 mg/mL
4.0 mL
0.5 mg/mL
Storage Conditions and Stability
Store reconstituted solutions at 2-8°C in a dedicated laboratory refrigerator, protected from direct light exposure. When using bacteriostatic water, the reconstituted blend maintains stability for up to 28 days under proper refrigerated conditions. Solutions prepared with sterile water require immediate use or division into single-use aliquots for frozen storage at -20°C or below.
Implement a clear labeling system indicating reconstitution date, concentration, and storage requirements. Monitor stored solutions for any signs of precipitation, cloudiness, or color changes that may indicate degradation or contamination.
Research Application Notes
Element SARMs' CJC-1295 and GHRP-2 blend offers researchers unprecedented opportunities to examine growth hormone pathway modulation in controlled experimental conditions. The reconstituted compound enables investigation of receptor binding kinetics, signal transduction cascades, and downstream metabolic effects in various in vitro model systems. Researchers should establish appropriate control groups and implement rigorous analytical methods to quantify experimental outcomes accurately.
All content is intended for in vitro laboratory research purposes only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any condition.
Hexarelin
TB-500
Epithalon
Ipamorelin
Tirzepatide
CJC-1295 DAC
PT-141
Semaglutide
Selank
BPC-157
Sermorelin
Melanotan 2
IGF LR3
Tesamorelin
AICAR
IGF-DES
GHRP 2
Albuterol
Tamoxifen
Letrozole
Clomiphene
Tadalafil
Clenbuterol
Anastrozole
Finasteride
Exemestane
Sildenafil
Yohimbine
Bacteriostatic Water Recent Posts Melanotan 2 (MT2): Mechanism, Research, and Safety Considerations Ipamorelin: The Selective GHRP, Explained Tesamorelin: The GHRH Analog Studied for Visceral Fat Sermorelin: The Original GHRH Analog, Explained CJC-1295: How the GHRH Analog Works, and What Research Shows
Already a customer? Sign In
Create Account
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
ElementSarms is a chemical supplier. ElementSarms is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. ElementSarms is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
Sarms
Stacks
Research Liquids
Albuterol 5MG/ML | 30ML with dropper
Anastrozole 1.5MG/ML | 30ML with dropper
Clomiphene 50MG/ML | 30ML with dropper
Finasteride 5MG/ML | 30ML with dropper
Letrozole 3.5 MG/ML | 30ML with dropper
LiquiCia 30MG/ML | 30ML with dropper
LiquiCia T50 50MG/ML | 30ML with dropper
LiquiClen 200MCG/ML | 30ML with dropper
Liquistane / Exemestane 25MG/ML | 30ML with dropper
LiquiTamo 20MG/ML | 30ML with dropper
LiquiVia 25MG/ML | 30 ML with dropper
T3 LIOTHYRONINE 200MCG/ML | 30ML with dropper
Toremifene Citrate 60MG/ML | 30ML with dropper
Yohimbine HCL 10MG/ML | 30ML with dropper
Research Peptides
Aicar 50MG
BPC-157 + TB-500 Blend 2mg ea/ 4MG
BPC-157 5MG
CJC-1295 + DAC 2MG
CJC-1295 | No DAC 2MG
Epithalon 10MG
Frag Premium 176-191 5MG
GHK-CU Copper Peptide 50MG
GHRP-2 5MG
GHRP-6 5MG
Hexarelin 5MG
IGF-1 DES 1MG
IGF-1 LR3 1MG
Ipamorelin 5MG
Melanotan 2 10MG
NAD+ 500MG
PT-141 / Bremelanotide 10MG
GLP-1/GIP/GCG (RT)
Selank 5MG
GLP1 (SM)
Sermorelin 5MG
TB-500 5MG
GIP/GLP-1 (TZ)
PDE5 Inhibitors
GLP-1
Diluents
Bacteriostatic Water 10ML